GPT and chronic kidney disease: Previous model validation and results from the current study reported no increase in liver function enzymes AST or ALT in CKD animals compared to control.8, 46 Accordingly, the observed changes in liver CYP2B1 expression and function are not attributed to direct hepatic damage.